
Soligenix Thermostable Vaccine Technology Addresses Critical Cold Chain Limitations
Soligenix's breakthrough thermostable vaccine technology demonstrates long-term stability at high temperatures, potentially solving the critical cold chain problem that causes over 50% of global vaccine waste and limits deployment in outbreak regions.
Read full story























